Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( ROBOHIT Trial)
International Journal of Urology · 2025
DOI: 10.1111/iju.70116 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Jun Teishima und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Graduate School of Medicine, Kobe University, Kobe, Japan. Hauptthemen laut MEDLINE: Nephrectomy, Robotic Surgical Procedures, Kidney Neoplasms, Carcinoma, Renal Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objectives
We aimed to evaluate the long‐term oncological and functional outcomes after robot‐assisted partial nephrectomy (RAPN) for renal hilar tumors.
Methods
A total of 22 academic hospitals in Japan participated in a prospective, multicenter, single‐arm, open‐label trial with a 2‐year enrollment period. After undergoing RAPN, 105 patients with clinical T1 renal hilar tumors were followed up for 5 years and evaluated. Recurrence‐free survival, overall survival, and trends of renal function were set as oncological and functional outcomes.
Results
Five‐year overall survival and recurrence‐free survival were 98.0% and 89.2%, respectively. Mean estimated glomerular filtration rates (eGFRs) were 69.031 mL/min preoperatively, and were 59.374, 58.334, 58.221, 56.975, and 59.602 mL/min at 1, 2, 3, 4, and 5 years after surgery, respectively. While eGFR was significantly lower than the preoperative one at all points ( p < 0.001), eGFRs at 1 and 5 years after surgery did not differ significantly ( p = 0.793).
Conclusion
After long‐term follow‐up, RAPN for clinical T1 renal hilar tumors continues to provide functional and oncological outcomes equivalent to those in the perioperative period. Trial Registration: The study protocol was registered in the Japan Registry of Clinical Trials (jRCT1052190005, UMIN000023968)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urology, Graduate School of Medicine, Kobe University, Kobe, Japan.
- Department of Urology, Fujita Health University, Toyoake, Japan.
- Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Division of Urology, Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan.
- Department of Urology, Kobe City Medical Center General Hospital, Kobe, Japan.
ORCID-Profile: Toshio Takagi, Yasuo Kohjimoto, Fumiya Hongo, Kensuke Bekku, Nobuyuki Hinata, Atsushi Okada, Tetsuya Yoshida, Shuji Isotani
Zitieren
APA
Teishima, J., Shiroki, R., Takagi, T., Eto, M., Morizane, S., Yamasaki, T., Kohjimoto, Y., Hongo, F., Tsujino, T., Bekku, K., Hinata, N., Okada, A., Yoshida, T., Kondo, T., Kawamorita, N., Yamamoto, H., Isotani, S., Shimbo, M., Nagayama, J., …, & Miyake, H. (2025). Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( ROBOHIT Trial). International Journal of Urology. https://doi.org/10.1111/iju.70116
Vancouver
Teishima J, Shiroki R, Takagi T, Eto M, Morizane S, Yamasaki T, et al. Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( ROBOHIT Trial). International Journal of Urology. 2025. doi:10.1111/iju.70116
BibTeX
@article{Teishima2025,
author = {Teishima, Jun and Shiroki, Ryoichi and Takagi, Toshio and Eto, Masatoshi and Morizane, Shuichi and Yamasaki, Toshinari and Kohjimoto, Yasuo and Hongo, Fumiya and Tsujino, Takuya and Bekku, Kensuke and Hinata, Nobuyuki and Okada, Atsushi and Yoshida, Tetsuya and Kondo, Tsunenori and Kawamorita, Naoki and Yamamoto, Hayato and Isotani, Shuji and Shimbo, Masaki and Nagayama, Jun and Yamaguchi, Kunihisa and Kinoshita, Hidefumi and Miyake, Hideaki},
title = {Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( ROBOHIT Trial)},
journal = {International Journal of Urology},
year = {2025},
doi = {10.1111/iju.70116}
}
EUVIMED